Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
IPOT | CSE | CAD | Delayed | |
ISCNF | OTC Markets | USD | Delayed | |
IPOT | CBOE Canada | CAD | Real-time |
Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.
Name | Age | Since | Title |
---|---|---|---|
Brett Allan | 37 | - | Member of Advisory Board |
Justin Cooper | - | - | Member of Advisory Board |
Mark Rypien | - | 2022 | Member of the Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review